Literature DB >> 6254875

Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.

M C Rattray, G M Peterman, L C Altman, L Corey, K K Holmes.   

Abstract

Lymphocyte transformation and production of lymphocyte-derived chemotactic factor in response to herpes simplex virus antigen were studied in 15 patients with initial genital herpes and 10 controls. The patients underwent frequent genital examinations, viral cultures, and weekly immunological studies for a period of 11 weeks. The production of lymphocyte-derived chemotactic factor was maximal in week 1 of the disease and declined to control levels by week 6. In contrast, lymphocyte transformation was lowest in week 1, reached a maximum by week 4, and declined to control levels by week 11. Production of lymphocyte-derived chemotactic factor in week 1 was significantly lower in nine patients who developed signs or symptoms of systemic herpes infection than in six who had localized disease. In addition, a marked but transient decline in the production of this lymphokine was observed in patients at the time of clinical recurrence. Virus-specific lymphocyte transformation correlated inversely with the duration of genital pain and lesions and did not correlate with the presence of systemic signs or symptoms. These findings indicate that during initial genital herpes infection the dynamics of lymphocyte transformation and those of lymphocyte-derived chemotactic factor production are different, and that the generation of this lymphokine is an early component of the cellular immune response in this disease. Furthermore, adequate produce of lymphocyte-derived chemotactic factor may be important in restricting herpes simplex virus to the genital area and preventing disease recurrence.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254875      PMCID: PMC551283          DOI: 10.1128/iai.30.1.110-116.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

Authors:  L E Rasmussen; G W Jordan; D A Stevens; T C Merigan
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

2.  Seroepidemiology of infectious due to members of the herpesvirus group.

Authors:  B B Wentworth; E R Alexander
Journal:  Am J Epidemiol       Date:  1971-11       Impact factor: 4.897

3.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

5.  Association of antigenic type of Herpesvirus hominis with site of viral recovery.

Authors:  W R Dowdle; A J Nahmias; R W Harwell; F P Pauls
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

6.  A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.

Authors:  L C Altman; R Snyderman; J J Oppenheim; S E Mergenhagen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

7.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

8.  Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus.

Authors:  G L Rosenberg; R Snyderman; A L Notkins
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; A Duffey
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

10.  Feedback inhibition of specifically sensitized lymphocytes.

Authors:  G B Mackaness; P H Lagrange; T E Miller; T Ishibashi
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  1 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.